Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults

Clinical Nutrition

Volumn 37, Issue 5, 2018, Pages 1752-1758

  Xia, Ming Feng ^a,b   Bian, Hua ^a,b   Zhu, Xiao Peng ^a,b   Yan, Hong Mei ^a,b   Chang, Xin Xia ^a,b   Zhang, Lin Shan ^a,b   Lin, Huan Dong ^a,b   Hu, Xi Qi ^a   Gao, Xin ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Fudan Institute for Metabolic Diseases   (China)

Author keywords

Folic acid; Liver biopsy; NAFLD; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLESTEROL; FOLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FAT CONTENT; FEMALE; FOLIC ACID BLOOD LEVEL; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; ODDS RATIO; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; BLOOD; CHINA; DNA METHYLATION; LIVER; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CHINA; DNA METHYLATION; FEMALE; FOLIC ACID; HUMANS; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; ROC CURVE;

EID: 85022073246     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2017.06.021     Document Type: Article

References (52)

1. Younossi, Z.M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9 (2011), 524–530.
2. de Alwis, N.M., Day, C.P., Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 48 (2008), S104–S112.
3. Armstrong, M.J., Adams, L.A., Canbay, A., Syn, W.K., Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59 (2014), 1174–1197.
4. Anstee, Q.M., Targher, G., Day, C.P., Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10 (2013), 330–344.
5. Masuzaki, R., Karp, S.J., Omata, M., NAFLD as a risk factor for HCC: new rules of engagement?. Hepatol Int 10 (2016), 533–534.
6. Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of followup. Hepatology 61 (2015), 1547–1554.
7. Welsh, J.A., Karpen, S., Vos, M.B., Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J Pediatr 162 (2013), 496–500.
8. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
9. Ogden, C.L., Carroll, M.D., Lawman, H.G., Fryar, C.D., Kruszon-Moran, D., Kit, B.K., et al. Trends in obesity prevalence among children and adolescents in the United States, 1988–1994 through 2013–2014. JAMA 315 (2016), 2292–2299.
10. Wesolowski, S.R., Kasmi, K.C., Jonscher, K.R., Friedman, J.E., Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol 14:2 (2017), 81–96.
11. Aguilar-Olivos, N.E., Oria-Hernández, J., Ponciano-Rodríguez, G., Chávez-Tapia, N.C., Uribe, M., Méndez-Sánchez, N., The role of epigenetics in the progression of non-alcoholic fatty liver disease. Mini Rev Med Chem 15 (2015), 1187–1194.
12. Sookoian, S., Rosselli, M.S., Gemma, C., Burgueño, A.L., Fernández Gianotti, T., Castaño, G.O., et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology 52 (2010), 1992–2000.
13. Murphy, S.K., Yang, H., Moylan, C.A., Pang, H., Dellinger, A., Abdelmalek, M.F., et al. Relationship between the methylome and transcriptome in patients with non-alcoholic fatty liver disease. Gastroenterology 145 (2013), 1076–1087.
14. Sookoian, S., Pirola, C.J., DNA methylation and hepatic insulin resistance and steatosis. Curr Opin Clin Nutr Metab Care 15 (2012), 350–356.
15. Da Silva, R.P., Kelly, K.B., Al Rajabi, A., Jacobs, R.L., Novel insights on interactions between folate and lipid metabolism. BioFactors 40 (2014), 277–283.
16. Pooya, S., Blaise, S., Moreno Garcia, M., Giudicelli, J., Alberto, J.M., Guéant-Rodriguez, R.M., et al. Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α ERR-α and HNF-4α in the rat liver. J Hepatol 57 (2012), 344–351.
17. Chew, T.W., Jiang, X., Yan, J., Wang, W., Lusa, A.L., Carrier, B.J., et al. Folate intake, MTHFR genotype, and sex modulate choline metabolism in mice. J Nutr 141 (2011), 1475–1481.
18. Pogribny, I.P., Kutanzi, K., Melnyk, S., de Conti, A., Tryndyak, V., Montgomery, B., et al. Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury. FASEB J 27 (2013), 2233–2243.
19. Wang, J., Wu, Z., Li, D., Li, N., Dindot, S.V., Satterfield, M.C., et al. Nutrition, epigenetics, and metabolic syndrome. Antioxid Redox Signal 17 (2012), 282–301.
20. Cordero, P., Gomez-Uriz, A.M., Campion, J., Milagro, F.I., Martinez, J.A., Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet. Genes Nutr 8 (2013), 105–113.
21. Gulsen, M., Yesilova, Z., Bagci, S., Uygun, A., Ozcan, A., Ercin, C.N., et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 20 (2005), 1448–1455.
22. Hirsch, S., Poniachick, J., Avendaño, M., Csendes, A., Burdiles, P., Smok, G., et al. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition 21 (2005), 137–141.
23. de Carvalho, S.C., Muniz, M.T., Siqueira, M.D., Siqueira, E.R., Gomes, A.V., Silva, K.A., et al. Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD). Nutr J, 12, 2013, 37.
24. Polyzos, S.A., Kountouras, J., Patsiaoura, K., Katsiki, E., Zafeiriadou, E., Zavos, C., et al. Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease. Int J Food Sci Nutr 63 (2012), 659–666.
25. Xia, M.F., Yki-Järvinen, H., Bian, H., Lin, H.D., Yan, H.M., Chang, X.X., et al. Influence of ethnicity on the accuracy of non-invasive scores predicting non-alcoholic fatty liver disease. PLoS One, 11, 2016, e0160526.
26. Tian, Y., Jiang, C., Wang, M., Cai, R., Zhang, Y., He, Z., et al. BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000-14. Lancet Diabetes Endocrinol 4 (2016), 487–497.
27. Fan, J.G., Saibara, T., Chitturi, S., Kim, B.I., Sung, J.J., Chutaputti, A., et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?. J Gastroenterol Hepatol 22 (2007), 794–800.
28. Hao, L., Ma, J., Stampfer, M.J., Ren, A., Tian, Y., Tang, Y., et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr 133 (2003), 3630–3635.
29. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 (2012), 2005–2023.
30. Farrell, G.C., Chitturi, S., Lau, G.K., Sollano, J.D., Asia-Pacific Working Party on NAFLD, Guidelines for the assessment and management of nonalcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22 (2007), 775–777.
31. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
32. Bian, H., Yan, H., Zeng, M., Rao, S., Yao, X., Zhou, J., et al. Increased liver fat content and unfavorable glucose profiles in subjects without diabetes. Diabetes Technol Ther 13 (2011), 149–155.
33. Szczepaniak, L.S., Nurenberg, P., Leonard, D., Browning, J.D., Reingold, J.S., Grundy, S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005), E462–E468.
34. The Asian Guidelines of National Cholesterol Education Program Adult Treatment Panel III (ATPIII); 2005.
35. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA;285:2486–2497.
36. Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L.M., et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137 (2009), 865–872.
37. Tibbetts, A.S., Appling, D.R., Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr 30 (2010), 57–81.
38. Stover, P.J., Field, M.S., Trafficking of intracellular folates. Adv Nutr 2 (2011), 325–331.
39. Mojtabai, R., Body mass index and serum folate in childbearing age women. Eur J Epidemiol 19 (2004), 1029–1036.
40. Mahabir, S., Ettinger, S., Johnson, L., Baer, D.J., Clevidence, B.A., Hartman, T.J., et al. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr 62 (2008), 644–650.
41. Farquhar, J.W., Gross, R.C., Wagner, R.M., Reaven, G.M., Validation of an incompletely coupled two-compartment nonrecycling catenary model for turnover of liver and plasma triglyceride in man. J Lipid Res 6 (1965), 119–134.
42. Verhaar, M.C., Stroes, E., Rabelink, T.J., Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 22 (2002), 6–13.
43. Robinson, K., Arheart, K., Refsum, H., Brattström, L., Boers, G., Ueland, P., et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 97 (1998), 437–443.
44. Morrison, H.I., Schaubel, D., Desmeules, M., Wigle, D.T., Serum folate and risk of fatal coronary heart disease. JAMA 275 (1996), 1893–1896.
45. Christensen, K.E., Wu, Q., Wang, X., Deng, L., Caudill, M.A., Rozen, R., Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J Nutr 140 (2010), 1736–1741.
46. Vance, D.E., Li, Z., Jacobs, R.L., Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology. J Biol Chem 282 (2007), 33237–33241.
47. Jacobs, R.L., Lingrell, S., Zhao, Y., Francis, G.A., Vance, D.E., Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein. J Biol Chem 283 (2008), 2147–2155.
48. Magoulas, P.L., El-Hattab, A.W., Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis, 7, 2012, 68.
49. Malaguarnera, M., Gargante, M.P., Russo, C., Antic, T., Vacante, M., Malaguarnera, M., et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis – a randomized and controlled clinical trial. Am J Gastroenterol 105 (2010), 1338–1345.
50. Champier, J., Claustrat, F., Nazaret, N., Fevre Montange, M., Claustrat, B., Folate depletion changes gene expression of fatty acid metabolism, DNA synthesis, and circadian cycle in male mice. Nutr Res 32 (2012), 124–132.
51. Sarna, L.K., Wu, N., Wang, P., Hwang, S.Y., Siow, Y.L., O K, Folic acid supplementation attenuates high fat diet induced hepatic oxidative stress via regulation of NADPH oxidase. Can J Physiol Pharmacol 90 (2012), 155–165.
52. Sid, V., Wu, N., Sarna, L.K., Siow, Y.L., House, J.D., O K, Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 309 (2015), R1215–R1225.